METHODS FOR USING TACI-IMMUNOGLOBULIN FUSION PROTEINS
    7.
    发明申请
    METHODS FOR USING TACI-IMMUNOGLOBULIN FUSION PROTEINS 有权
    使用TACI-IMMUNOGLOBULIN融合蛋白的方法

    公开(公告)号:US20130309231A1

    公开(公告)日:2013-11-21

    申请号:US13956499

    申请日:2013-08-01

    IPC分类号: C07K16/24

    摘要: Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.

    摘要翻译: 干扰肿瘤坏死因子受体与其配体如可溶性受体的结合的分子已被证明在基础研究和治疗中都是有用的。 本发明提供改进的可溶性跨膜激活剂和钙调节剂和亲环蛋白配体相互作用(TACI)受体。